Bloomwell Group GmbH

Bloomwell Group GmbH operates what it describes as Germany's leading digital platform for medical cannabis therapy. The company runs a telemedicine-first patient journey: digital consultations with medical professionals, a patient-facing mobile application, and discreet home delivery of treatment. Its platform is used by more than 500,000 patients, and the stated mission is to make healthcare more accessible and to destigmatise medical cannabis as a treatment option.

The product stack spans a Flutter-based mobile app, remote digital consultations and a delivery service that closes the loop from consultation to treatment. Engineering work covers digital health platform development, mobile application development and CI/CD pipeline optimisation. The firm operates at the intersection of healthcare, telemedicine, pharmaceuticals and alternative treatments.

The company describes a cross-functional working culture, with engineers working alongside medical professionals and marketing teams partnering with patient advocates. It positions itself as a startup-minded organisation in a rapidly evolving industry, with offices in Frankfurt and a remote-first approach. Roles at Bloomwell are framed around autonomy, purpose and impact, with work said to affect patient outcomes across Germany.

Team size, founding year and funding details are not disclosed. More information is available at bloomwell.de.